Your browser doesn't support javascript.
loading
Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis.
Fu, Rong; Chen, Yan; Wang, Xiao-Ping; An, Teng; Tao, Lei; Zhou, Yu-Xin; Huang, Yu-Jie; Chen, Bao-An; Li, Zhi-Yu; You, Qi-Dong; Guo, Qing-Long; Wu, Zhao-Qiu.
Afiliación
  • Fu R; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • Chen Y; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • Wang XP; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • An T; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • Tao L; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • Zhou YX; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • Huang YJ; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • Chen BA; Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing 211189, China.
  • Li ZY; Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China.
  • You QD; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
  • Guo QL; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
  • Wu ZQ; Department of Physiology, State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, China.
Oncotarget ; 7(5): 5715-27, 2016 Feb 02.
Article en En | MEDLINE | ID: mdl-26735336
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Asunto principal: Proteínas Proto-Oncogénicas c-myc / Inhibidores de la Angiogénesis / Flavanonas / Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau / Subunidad alfa del Factor 1 Inducible por Hipoxia / Mieloma Múltiple / Neovascularización Patológica Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Asunto principal: Proteínas Proto-Oncogénicas c-myc / Inhibidores de la Angiogénesis / Flavanonas / Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau / Subunidad alfa del Factor 1 Inducible por Hipoxia / Mieloma Múltiple / Neovascularización Patológica Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China